Since METS is the crude extract from the marine sponge, it shows a high drug sensitivity (IC50 4.5 μg/mL) for oral cancer treatment; however, the in vivo antioral cancer effects of METS were not investigated. Here, ETV3 is linked to lip and oral cavity carcinoma.